Search












The lists contain medicinal products or product categories subject to prescription which shall not bear the safety features (White list) and medicinal products or product categories not subject to prescription which shall bear the safety features (Black list)
Number of records: 5289
Name of the medicinal product Supplement
SÚKL code Registration Number SPC ? PIL ? ATC group MA status ?
BENDAMUSTINE ACCORD 2,5MG/ML INF PLV CSL 1X100MG
0129697 44/ 594/15-C     L01AA09 B
BENDAMUSTINE ACCORD 2,5MG/ML INF PLV CSL 5X100MG
0129698 44/ 594/15-C     L01AA09 B
BENDAMUSTINE ACCORD 2,5MG/ML INF PLV CSL 10X25MG
0129694 44/ 594/15-C     L01AA09 B
BENDAMUSTINE ACCORD 2,5MG/ML INF PLV CSL 5X25MG
0129693 44/ 594/15-C     L01AA09 B
BENDAMUSTINE ACCORD 2,5MG/ML INF PLV CSL 20X25MG
0129695 44/ 594/15-C     L01AA09 B
BENDAMUSTINE ACCORD 2,5MG/ML INF PLV CSL 5X25MG
0241289 44/ 594/15-C bendamusti.pdf bendamusti.pdf L01AA09 R
BENDAMUSTINE ACCORD 2,5MG/ML INF PLV CSL 5X100MG
0241293 44/ 594/15-C bendamusti.pdf bendamusti.pdf L01AA09 R
BENDAMUSTINE ACCORD 2,5MG/ML INF PLV CSL 1X100MG
0241292 44/ 594/15-C bendamusti.pdf bendamusti.pdf L01AA09 R
BENDAMUSTINE ACCORD 2,5MG/ML INF PLV CSL 20X25MG
0241291 44/ 594/15-C bendamusti.pdf bendamusti.pdf L01AA09 R
BENDAMUSTINE ACCORD 2,5MG/ML INF PLV CSL 10X25MG
0241290 44/ 594/15-C bendamusti.pdf bendamusti.pdf L01AA09 R
BENDAMUSTINE GLENMARK 2,5MG/ML INF PLV CSL 5X25MG
0134999 44/ 256/16-C bendamusti.pdf bendamusti.pdf L01AA09 R
BENDAMUSTINE GLENMARK 2,5MG/ML INF PLV CSL 10X25MG
0135000 44/ 256/16-C bendamusti.pdf bendamusti.pdf L01AA09 R
BENDAMUSTINE GLENMARK 2,5MG/ML INF PLV CSL 20X25MG
0135012 44/ 256/16-C bendamusti.pdf bendamusti.pdf L01AA09 R
BENDAMUSTINE GLENMARK 2,5MG/ML INF PLV CSL 1X25MG
0134998 44/ 256/16-C bendamusti.pdf bendamusti.pdf L01AA09 R
BENDAMUSTINE GLENMARK 2,5MG/ML INF PLV CSL 1X100MG
0135013 44/ 256/16-C bendamusti.pdf bendamusti.pdf L01AA09 R
BENDAMUSTINE GLENMARK 2,5MG/ML INF PLV CSL 5X100MG
0135014 44/ 256/16-C bendamusti.pdf bendamusti.pdf L01AA09 R
BENDAMUSTINE KABI 2,5MG/ML INF PLV CSL 5X100MG
0235083 44/ 337/16-C bendamusti.pdf bendamusti.pdf L01AA09 R
BENDAMUSTINE KABI 2,5MG/ML INF PLV CSL 1X100MG
0235082 44/ 337/16-C bendamusti.pdf bendamusti.pdf L01AA09 R
BENDAMUSTINE KABI 2,5MG/ML INF PLV CSL 20X25MG
0235081 44/ 337/16-C bendamusti.pdf bendamusti.pdf L01AA09 R
BENDAMUSTINE KABI 2,5MG/ML INF PLV CSL 10X25MG
0235080 44/ 337/16-C bendamusti.pdf bendamusti.pdf L01AA09 R

‹‹ ‹ 10 19 20 21 22 23 24 25 26 27 28 29 40 50 60 70 80 100 200 › ››

Medicinal products reimbursed from health insurance are blue-tinged and marked with sign.

Medicinal products on the Czech market in line with periodical report from wholesalers in last 3 months (with monthly distance) are sign and are typed in bold

Last update of registration information: 18. January 2022 at 00:08
Last update of price and payment data: 1. January 2022 at 00:11